Skip to main navigation Skip to search Skip to main content

Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?

  • Gianfranco Ferraccioli*
  • , Stefano Alivernini
  • , Barbara Tolusso
  • , Elisa Gremese
  • *Corresponding author

Research output: Contribution to journal › Article

Abstract

N/A
Original languageEnglish
Pages (from-to)636-638
Number of pages3
JournalAutoimmunity Reviews
Volume17
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antinuclear antibodies
  • Cardiovascular disease
  • Immunology
  • Immunology and Allergy
  • Interstitial lung disease
  • Mortality
  • Peripheral venous thrombosis
  • Rheumatoid factor

Fingerprint

Dive into the research topics of 'Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”?'. Together they form a unique fingerprint.

Cite this